Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice – A mixed methods study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice – A mixed methods study

Published:2024-10 Issue: Volume:210 Page:114269
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kruiswijk Anouk A.,Engelhardt Ellen G.,Vlug Lisa A.E.,van de Wal Robert J.P.,Schrage Yvonne M.,Haas Rick L.,van de Sande Michiel A.J.,Marang-van de Mheen Perla J.,van Bodegom-Vos Leti

Funder

Dutch Cancer Society

Publisher

Elsevier BV

Reference35 articles.

1. WHO Classification of Tumours Editorial Board: Soft Tissue and Bone Tumours. 5th ed. 2020, Lyon, France: International Agency for Research on Cancer.

2. Cancer statistics, 2021;Siegel;Ca-a Cancer J Clin,2021

3. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project.;Stiller;Eur J Cancer,2013

4. Patient decision aid (PDA) for patients with rheumatoid arthritis reduces decisional conflict and improves readiness for treatment decision making;Pablos;Patient-Patient Cent Outcomes Res,2020

5. Decisional conflict in patients and their physicians: a dyadic approach to shared decision making;LeBlanc;Med Decis Mak,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP